NK
Naveen Kumar Srivastava
About Naveen Kumar Srivastava
Data last updated:
Naveen Kumar Srivastava has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Anvisa Pharmaceuticals Private Limited and Myrrhis Future India Private Limited. Formerly with 1 company, such as Novokon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Mar 2025 | 2025 | – | Active | |
| Director | 25 Feb 2022 | 2022 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Mar 2019 | 2019 | ₹64.6 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naveen Kumar Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naveen Kumar Srivastava
Naveen Kumar Srivastava has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Anvisa Pharmaceuticals Private Limited and Myrrhis Future India Private Limited. Formerly with 1 company, such as Novokon Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Naveen Kumar Srivastava is associated with 2 companies as Director, including Myrrhis Future India Private Limited, Anvisa Pharmaceuticals Private Limited.
Naveen Kumar Srivastava has expertise in General Business.
Naveen Kumar Srivastava has 7 years in corporate governance.
Naveen Kumar Srivastava currently holds positions at 2 companies: Myrrhis Future India Private Limited, Anvisa Pharmaceuticals Private Limited.